18F-FDG PET maximum intensity projections and artificial intelligence: a win-win combination to easily measure prognostic biomarkers in DLBCL patients

Kibrom Berihu Girum; Louis Rebaud; Anne-Ségolène Cottereau; Michel Meignan; Jérôme Clerc; Laetitia Vercellino; Olivier Casasnovas; Franck Morschhauser; Catherine Thieblemont; Irène Buvat

doi:10.2967/jnumed.121.263501

OtherAI/Advanced Image Analysis

Open Access

¹⁸F-FDG PET maximum intensity projections and artificial intelligence: a win-win combination to easily measure prognostic biomarkers in DLBCL patients

Kibrom Berihu Girum, Louis Rebaud, Anne-Ségolène Cottereau, Michel Meignan, Jérôme Clerc, Laetitia Vercellino, Olivier Casasnovas, Franck Morschhauser, Catherine Thieblemont and Irène Buvat

Journal of Nuclear Medicine June 2022, jnumed.121.263501; DOI: https://doi.org/10.2967/jnumed.121.263501

Kibrom Berihu Girum

1 LITO laboratory, UMR 1288 Inserm, Institut Curie, University Paris Saclay, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Kibrom Berihu Girum

Louis Rebaud

2 LITO laboratory, UMR 1288 Inserm, Institut Curie, University Paris Saclay; Research and Clinical Collaborations, Siemens Medical Solutions USA, 810 Innovation Dr, Knoxville, TN 37932, United states, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Anne-Ségolène Cottereau

3 LITO laboratory, UMR 1288 Inserm, Institut Curie, University Paris-Saclay, Orsay, France; Department of Nuclear Medicine, Cochin Hospital, AP-HP, Paris Descartes University, Paris, France, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Anne-Ségolène Cottereau

Michel Meignan

4 Lysa Imaging, Henri Mondor University Hospital, AP-HP, University Paris East, Creteil, France, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Michel Meignan

Jérôme Clerc

5 Department of Nuclear Medicine, Cochin Hospital, AP-HP, Paris Descartes University, Paris, France, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Jérôme Clerc

Laetitia Vercellino

6 Department of Nuclear Medicine, Saint-Louis Hospital, AP-HP, Paris, France, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Olivier Casasnovas

7 Department of Hematology, University Hospital of Dijon, Dijon, France, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Franck Morschhauser

8 Department of Hematology, Claude Huriez hospital, University Lille, EA 7365, Research Group on Injectable Forms and Associated Technologies, Lille, France, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Catherine Thieblemont

9 Department of Hematology, Saint Louis Hospital, AP-HP, Paris, France, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Irène Buvat

1 LITO laboratory, UMR 1288 Inserm, Institut Curie, University Paris Saclay, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Irène Buvat

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 66, Issue 1

January 1, 2025

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following 18F-FDG PET maximum intensity projections and artificial intelligence: a win-win combination to easily measure prognostic biomarkers in DLBCL patients

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

¹⁸F-FDG PET maximum intensity projections and artificial intelligence: a win-win combination to easily measure prognostic biomarkers in DLBCL patients

Kibrom Berihu Girum, Louis Rebaud, Anne-Ségolène Cottereau, Michel Meignan, Jérôme Clerc, Laetitia Vercellino, Olivier Casasnovas, Franck Morschhauser, Catherine Thieblemont, Irène Buvat

Journal of Nuclear Medicine Jun 2022, jnumed.121.263501; DOI: 10.2967/jnumed.121.263501

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

¹⁸F-FDG PET maximum intensity projections and artificial intelligence: a win-win combination to easily measure prognostic biomarkers in DLBCL patients

Kibrom Berihu Girum, Louis Rebaud, Anne-Ségolène Cottereau, Michel Meignan, Jérôme Clerc, Laetitia Vercellino, Olivier Casasnovas, Franck Morschhauser, Catherine Thieblemont, Irène Buvat

Journal of Nuclear Medicine Jun 2022, jnumed.121.263501; DOI: 10.2967/jnumed.121.263501

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

PubMed
Google Scholar

Cited By...

Integration of clinical, pathological, radiological, and transcriptomic data improves the prediction of first-line immunotherapy outcome in metastatic non-small cell lung cancer
Promising Candidate Prognostic Biomarkers in [18F]FDG PET Images: Evaluation in Independent Cohorts of Non-Small Cell Lung Cancer Patients
Tumor Location Relative to the Spleen Is a Prognostic Factor in Lymphoma Patients: A Demonstration from the REMARC Trial

Google Scholar

Keywords

image processing
Oncology: Lymphoma
PET/CT
18F FDG PET/CT
artificial intelligence
DLBCL
Dissemination
metabolic tumor volume

Main menu

User menu

Search

¹⁸F-FDG PET maximum intensity projections and artificial intelligence: a win-win combination to easily measure prognostic biomarkers in DLBCL patients

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

Similar Articles

Keywords